AC Immune SA financial data

Symbol
ACIU on Nasdaq
Location
Epfl Innovation Park, Building B, 1015 Lausanne, Switzerland
State of incorporation
Switzerland
Fiscal year end
December 31
Latest financial report
20-F - Q4 2023 - Mar 14, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99.2M shares +18.6%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 13.7M CHF -12.8%
General And Administrative Expense 3.68M CHF -15.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 183M CHF -1.68%
Liabilities 22.2M CHF +30.8%